Rebalix
Logo LGIMLGIM · sheet of 10 September 2026
ETF sheet · official issuer and register data

L&G Europe ex UK Equity UCITS ETF

LGEU · IE00BFXR5V83 · class EUR Acc. · EUR · domicile Ireland
Equity · Europe · Mid capSFDR art. 8
Index tracked: Solactive Core Developed Markets Europe ex UK Large & Mid Cap Index NTR
TER
0.10%+ trans. 0.02%
Fund size
984 m EUR
Tracking difference
+0.38%3-year avg
🇮🇹 tax rate
white list not published
Replication
Physical (full replication)
Income
Accumulating
Launch 13 Nov 2018 · costs from the KID as of 2 Sept 2026 · 0 securities held · 10 venues (ESMA register)

The fund’s objective — in the issuer’s words

From the Key Information Document (KID) · 4 Aug 2026
The investment objective of the Fund is to provide exposure to the large and mid-cap equity market in the developed market countries in Europe, excluding the United Kingdom. The Fund is passively managed and aims to track the performance of the Solactive Core Developed Markets Europe ex-UK Large & Mid Cap EUR Index NTR (the “Index”), before the deduction of fees and expenses. The Index is designed to provide exposure to large- and mid capitalisation companies in developed market countries in Europe, excluding the United Kingdom, in accordance with its…

Performance since series start (in euro) — base 100

7 Nov 201831 Jul 2026 · dividends reinvested where declared by the issuer
201920212023202522584223
High 225 (6 Jul 2026) · low 84 (17 Mar 2020) · last 223. Past performance is not indicative of future results.

Returns in euro

1 year+21.3%
3 years+47.6%
5 years+57.7%
10 yearsseries too young
Since series start+123.3%

Risk · 1 / 3 / 5 years

Volatility (ann.)13.02%12.94%14.54%
Max drawdown−10.06%−16.37%−22.47%
Sharpe1.370.910.50
Sortino2.141.290.70
Sharpe/Sortino: risk-free = ECB MRO avg; nominal volatility
Rebalix · LGEU · IE00BFXR5V831
RebalixLGEU · IE00BFXR5V83 · sheet of 10 September 2026

Tracking difference — year by year

Fund minus index, complete calendar years · from issuer-declared series
YearFundIndexTD
2025+20.16%+19.76%+0.41%
2024+7.02%+6.69%+0.32%
2023+18.50%+18.09%+0.41%
2022−12.49%−12.79%+0.30%
2021+25.36%+24.28%+1.09%

Holdings

Portfolio as declared by the issuer · 30 Jun 2026 · 0 securities · top-10 weight = 24.9%
Top holdingsWeight
ASML5.9%
Roche2.9%
Novartis2.7%
Nestle2.4%
Siemens2.2%
Banco Santander1.9%
Allianz1.8%
SAP1.7%
Schneider Electric1.7%
TotalEnergies1.7%
Countries (% of fund)
Svizzera18.1%Germania17.4%Francia16.9%Paesi Bassi12.3%Spagna7.5%
Sectors (% of fund)
Finanziari25.8%Industriali20.0%Assistenza sanitaria13.2%Informatica10.9%Beni di consumo voluttuari7.2%

Listing venues

ESMA register (FIRDS) and official exchange lists
LGEU · Borsa Italiana (ETFplus), Euronext Amsterdam
ETLN · Börse Düsseldorf, Börse Frankfurt, Börse Hamburg, Börse Hannover, Börse München / gettex, Börse Stuttgart, Tradegate Exchange, Xetra (Deutsche Börse)
+ 13 unmapped venues (MTF, RFQ, professional)

Official documents

Clickable links in the PDF
KID · fundcentres.landg.com/srp/documents-id/ce7fce8f-7019-408f-aec6-eaa2199
Factsheet · fundcentres.landg.com/srp/documents-id/3827e896-1a0c-47ac-80eb-b11f137
Prospectus · fundcentres.landg.com/srp/lit/7qeQjP/Prospectus_Legal-General-UCITS-ET
The live sheet, always up to date
rebalix.com/en/etf/IE00BFXR5V83
Series, distributions, holdings and documents refresh daily.
Sheet produced on 10 September 2026 · data as of the dates shown section by section. Sources: official issuer documents (KID, factsheet, NAV and total-return series, declared portfolio), ESMA register (FIRDS), European Central Bank (FX), Italian tax authority / issuer (white-list share). Public methodology: rebalix.com/en/methodology. “—” = not published by the source, never estimated.

Informational document generated by rebalix.com: facts only, no recommendations. Not investment advice or investment research under Directive 2014/65/EU (MiFID II), nor an offer or solicitation. Past performance is not indicative of, nor a guarantee of, future results; the value of an investment can go down as well as up. Before any decision read the issuer’s KID and Prospectus; tax treatment depends on individual circumstances. Trademarks and logos belong to their respective owners and only identify the instrument and its issuer: no affiliation, sponsorship or endorsement.

Rebalix · LGEU · IE00BFXR5V832